Real-World Outcomes Explored in Studies of Bevacizumab Biosimilar for Metastatic Colorectal Cancer - AJMC.com Managed Markets Network

Abstracts presented at the 2022 American Society of Clinical Oncology Annual Meeting show bevacizumab-awwb to be safe and effective for patients with metastatic colorectal cancer (mCRC) with high overall survival rates.

Two abstracts presented at the recent 2022 American Society of Clinical Oncology Annual Meeting discussed research on the real-world effectiveness and safety outcomes of patients with metastatic colo… [+4865 chars]

full article...